Enantioselective bioreduction of propentofylline using yeast in water and organic solvents

Biotechnologia

Volumn , Issue 2, 2007, Pages 174-180

  Pȩkala, Elzbieta ^a,b   Latacz, Gniewomir ^a   Wójcik, Tomasz ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Enantiomeric excess; Metabolites of propentofylline; Propentofylline; Saccharomyces cerevisiae

Indexed keywords

SACCHAROMYCES CEREVISIAE;

EID: 34547260947     PISSN: 08607796     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Plaschke K., Grant M., Weigand M. A., Züchner J., Martin E., Bardenheuer H. J, (2001), Br. J. Pharmacol., 133, 107-116.
2. Koriyama Y., Chiba K., Mohri., (2003), Eur. J. Pharm., 458, 235-241.
3. Chauhan N. B., Siegel G. J., Feinstein D. L., (2005), Neuropharmacology, 48, 93-104.
4. Ringheim G. E., (2000), Ann. N. Y. Acad. Sci., 903, 529-534.
5. Raghavendra V., Tanga F., Rutkowski M. D., DeLeo J. A., (2003), Pain, 104, 655-664.
6. Raghavendra V., Tanga F., DeLeo J. A., (2004), Nuuropsychopharmacology, 29, 327-334.
7. Wirtz-Brugger F., Giovanni A., (2000), Neuroscience, 99 (4), 737-750.
8. Kuroda N., Hamachi Y., Aoki N., Wada M., Tanigawa M., Nakashima K., (1999), Biomed. Chromat., 13(5), 340-343.
9. Minami M., Arai H., Takahashi T., Kimura M., Noguchi I., Suzuki T., Inoue R., (1995), Prog. Neuro-Psychopharmacol. and Biol. Psychiat., 19, 59-64.
10. Kwon O., Ryu J-C., (2000), Arch. Pharm. Res., 23 (4), 374-380.
11. Furrer H., Gebert U., Rudolphi K., (Hoechst, Frankfurt am Main, Germany), (1995), US Patent 5, 407, 815.
12. thed., 2, 160-184, Springer Verlag, Berlin.
13. Amidjojo M., Franco-Lara E., Nowak A., Link H., Weuster-Botz D., (2005), Appl. Microb. Biotechnol., 69, 9-15.
14. Ernst M., Kaup B., Müller M., Bringer-Meyer S., Sahm H., (2005), Appl. Microbiol. Biotechnol., 66, 629-634.